The University of Sydney
Understanding How Vyvanse Works to Treat Binge-Eating Disorder
| Chief Investigator | Closing Date |
|---|---|
| A/Prof Michael Kohn; Dr Kristi Griffiths | 31 Dec, 2019 |
| Chief Investigator | A/Prof Michael Kohn; Dr Kristi Griffiths |
|---|---|
| Closing Date | 31 Dec, 2019 |
About the research trial
Do you binge-eat at least 3 days a week? Are you distressed about your binge eating?
You may be eligible to participate in a clinical trial looking at how the medication VYVANSE works to reduce binge-eating symptoms.
The trial runs for 8 weeks and you would need to:
* Attend Westmead Institute for Medical Research & Westmead Hospital twice (before medication and after 8 weeks of medication) to complete interviews, questionnaires, cognitive tests, and brain scans.
* Have a blood pressure check at week 2, at Westmead or by your GP.
* Have a doctors appointment at Westmead Hospital at week 4, to check your medication dose.
During the trial, you would not be able to use any other treatments for your binge-eating symptoms.
This study is sponsored by the University of Sydney and has been approved by the WSLHD Human Research Ethics Committee.
Recruitment details
You may be eligible to participate in a clinical trial looking at how the medication VYVANSE works to reduce binge-eating symptoms, if:
- You are 18 - 40 years old
- You have Moderate to Severe Binge-Eating Disorder
- Your Body Mass Index is 20 - 45kg/m2 - use BMI calculator at http://www.health.nsw.gov.au/heal/Pages/bmi.aspx